Jan Grimm MD
Assistant Professor, Radiology, Weill Cornell Medical College
Join to View Full Profile
1275 York AveNew York, NY 10065
Phone+1 646-888-3095
Dr. Grimm is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Univ Hamburg- Fac MedClass of 1995
Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine
Certifications & Licensure
NY State Medical License 2009 - 2026
NJ State Medical License 2023 - 2025
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Diagnostic Radiology
Clinical Trials
- Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes Start of enrollment: 2012 Aug 08
- A Study of Optical Imaging With Light From Radiotracers in Cancer Patients Start of enrollment: 2018 Mar 20
Publications & Presentations
PubMed
- Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System.Edwin C Pratt, Travis M Shaffer, David Bauer, Jason S Lewis, Jan Grimm
Journal of Nuclear Medicine. 2025-03-13 - Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies.Magdalena Skubal, Benedict Mc Larney, Ngan Bao Phung, Juan Carlos Desmaras, Abdul Vehab Dozic
Theranostics. 2025-01-01 - In vivo imaging of ferroptosis through nanodynamic changes in lipid membranes.Ali Yasin Sonay, Benedict Edward Mc Larney, Elana Apfelbaum, Jan Grimm
Biorxiv. 2024-10-25
Press Mentions
MSK Research Highlights September 18, 2024September 18th, 2024- Ready, Set, Share!January 27th, 2023
- New Technique Could Reduce Cost, Improve Access to PET ScansApril 26th, 2022
- Join now to see all
Grant Support
- Multicolor PET to interrogate cancer biologySLOAN-KETTERING INST CAN RESEARCH2023–2027
- PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapySLOAN-KETTERING INST CAN RESEARCH2021–2026
- PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapySLOAN-KETTERING INST CAN RESEARCH2021–2026
- PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapySLOAN-KETTERING INST CAN RESEARCH2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
